Abion's Series A - II Round

Abion raised a round of funding on February 07, 2013. Investors include NAU IB Capital.

Abion (에이비온) (KONEX: 203400), fka Reference Biolabs (레퍼런스 바이오 랩), specializes in the development of biopharmaceutical drugs and companion diagnostics systems for the treatment …

Articles about Abion's Series A - II Round: